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Abstract: Cholesterol is indispensable for cellular membrane composition and function. It is also
a precursor for the synthesis of steroid hormones, which promote, among others, the maturation
of fetal organs. A role of the ATP-binding-cassette-transporter-A1 (ABCA1) in the transport of
maternal cholesterol to the fetus was suggested by transferring cholesterol to apolipoprotein-A-1
(apo-A1), but the directionality of the apoA-1/ABCA1-dependent cholesterol transport remains
unclear. We isolated primary trophoblasts from term placentae to test the hypotheses that
(1) apoA-1/ABCA1 dispatches cholesterol mainly towards the fetus to support fetal developmental
maturation at term, and (2) differentiated syncytiotrophoblasts (STB) exert higher cholesterol transport
activity than undifferentiated cytotrophoblasts (CTB). As experimental models, we used (1) trophoblast
monolayers grown on Transwell® system consisting of apical (maternal-like) and basal (fetal-like)
compartments, and (2) trophoblasts grown on conventional culture plates at CTB and STB stages.
Surprisingly, apoA-1-mediated cholesterol efflux operated almost exclusively at the apical-maternal side,
where ABCA1 was also localized by immunofluorescence. We found greater cholesterol efflux capacity
in STB, which was increased by liver-X-receptor agonist treatment and decreased by ABCA1 inhibition.
We conclude that at term the apoA-1/ABCA1 pathway is rather involved in cholesterol transport to the
mother than in transfer to the fully developed fetus.
Keywords: ABC transporter; cholesterol; fetal development; pregnancy; trans-placental
transport; trophoblasts
1. Introduction
Cholesterol is a crucial component of the biological membranes of all mammals, being involved
in maintenance of cell integrity and cellular functions [1]. It is also a precursor for the synthesis
of steroid hormones (e.g., progesterone and prednisolone), which are, amongst others, critically
important for pregnancy maintenance and/or maturation of fetal organs, such as the lung [2–4].
During pregnancy, the mother adapts her secretory activities to maintain a delicate balance between
her own physiological needs and the requirements of the fetus for embryogenesis, organogenesis,
or late maturation. An increase in circulating maternal cholesterol occurs in the third trimester, when
fetal maturation takes place [5]. In addition, investigations in mice showed that lung hypoplasia and
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delayed vascular development in late gestation are associated with insufficient maternal cholesterol
delivery [3]. Thus, understanding the mechanisms of cholesterol delivery to the fetus is not only
important during the first trimester in terms of embryogenesis, but also throughout the third trimester
in the context of complemental fetal growth and maturation of all organ systems indispensable for
immediate survival after birth.
Overall, the delivery of maternal cholesterol to the fetus depends on the placental abundance of
cholesterol transporters and receptors. ATP-binding cassette (ABC) transporter proteins are cellular
transmembrane proteins that mediate lipid efflux from cells to lipoprotein particles. Two major
members of the ABC transporter family, ABCA1 and ABCG1, were shown to be implicated in
cellular cholesterol transfer to lipid poor apolipoprotein (apo)-A1 and high-density lipoprotein
(HDL), respectively [6–8]. During the transport process across the placenta, cholesterol has to pass
physiological barriers separating the maternal from the fetal circulation. These barriers consist of
the syncytiotrophobast layer (STB), a multinucleated layer of fused precursor cytotrophoblasts (CTB)
facing the maternal circulation, and the fetal endothelium, composed of endothelial cells, localized at
the basal (fetal) side of the STB [9,10].
Several studies have identified ABCA1 and ABCG1 in placental tissues and cells at various cellular
localizations [11–14]. Further investigations revealed that only the abundance of placental ABCA1
(but not ABCG1) exhibited dependence on the gestational age [14], supporting the involvement of
ABCA1 with adequate in utero development of the fetus. In support of this assumption, a decrease of
placental ABCA1 expression and cholesterol transport activity was observed in the gestational disease
pre-eclampsia [14,15]. Moreover, deletion of ABCA1 in mice led to an approximately 30% decrease in
transfer of maternal cholesterol to the fetus, while suppression of ABCG1 did not affect the transfer
process [16]. A recent study in humans revealed also a highly significant correlation between maternal
ABCA1 genotypes and the severity in Smith-Lemli-Opitz syndrome (SLOS) [17]. The treatment of
pregnant female mice with an agonist of the liver-X-receptor (LXR) transcription factor has been
suggested as a potential therapeutic treatment of SLOS [16,18]. LXR is a key regulator of the expression
of multiple genes implicated in cholesterol homeostasis and transport such as ABCA1, sterol-response
element binding protein 2 (SREBP-2), scavenger receptor B1 (SR-B1) [19–23], or low-density lipoprotein
(LDL) receptor (LDL-R). SR-B1 is involved in both inward and outward transport [24], while LDL-R
mediates inward cholesterol uptake from lipoprotein particles [25].
To date, the directionality and underlying regulation of apoA-1 mediated transplacental
cholesterol transport is not fully elucidated. Thus, the objectives of this study were to compare (1) the
expression of selected cholesterol homeostatic genes, and (2) the orientation of the apoA-1 mediated
cholesterol efflux in a highly physiological model [26], namely primary trophoblast cells isolated
from human term placentas. The isolated trophoblasts were tested before and after in vitro
differentiation, the latter being characterized by spontaneous formation of a functional syncytium
in vitro. We hypothesized that (1) cholesterol transport capabilities are increased in differentiated
(STB) as compared to undifferentiated (CTB) trophoblasts, and (2) cholesterol efflux to apoA-1 is
predominantly oriented towards the basal (fetal) side of the STB to support the high fetal demands
and fetal organ maturation close to birth.
2. Results and Discussion
The present study discusses maternal–fetal cholesterol transport in and across the placenta at
term when the maturation of fetal tissues and organs occurs. The study elicits the cholesterol transport
capacities of trophoblasts in relation to their differentiation state and provides new insights into the
directionality of the apoA-1/ABCA1-mediated cholesterol transport at term.
2.1. Characterization of Isolated Trophoblasts and Efficiency of In Vitro Differentiation
The purity of isolated primary CTB from tissue specimens is critically important, and potential
cellular contamination might influence the interpretation of in vitro studies [27]. In the current study,
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trophoblasts were isolated following the previously published isolation protocol [13], complemented
by a detailed routine evaluation of cellular identity and physiological features.
2.1.1. Cell Morphology
Freshly isolated primary cells appeared like single nucleated and cuboid cells with well-demarcated
cell borders, corresponding to trophoblasts (CTB) [13] (Figure 1, left panel). After 3-days of cultivation CTB
have fused and formed multinucleated cellular entities representing the syncytium (Figure 1, right panel).
These cells appear as a continuous layer without intercellular boundaries, and form island-like shapes
when grown on conventional culturing plates. In general, syncytium (STB) formation starts already 24 h
after cultivation [13], and STB maintain their morphological characteristics over several days.
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cadherin have been chosen, because they are commonly used markers for epithelial cells [28,29]. We 
also assessed to which extent potential cellular contamination by mesenchymal cells or endothelial 
cells occurred and/or have been propagated with cultivation. To this end, the expression of vimentin 
and vWF was analyzed to evaluate the presence of mesenchymal and endothelial cells, respectively 
[28–30]. As shown in Figure 2B (left and right panels), there were clear increases in fluorescence as 
compared to the isotype controls, indicating that both CTB and STB express high levels of CK7. The 
degree of CK7 positivity in CTB and STB was above 85% (Figure 2A,B), suggesting high purity and 
stability of the trophoblast cultures. Additional purification by negative immuno-magnetic selection 
[13] was not performed due to the lack of substantial improvement of purity. 
The cellular costaining for CK7 and vimentin positivity confirmed the predominantly epithelial 
character of the isolated cells: CK-positivity ranged from ~84 to 86%, while vimentin-positivity was 
between ~8 and 12% (Figure 2C,D). These data indicated the absence of significant mesenchymal 
contaminations and excluded the propagation/overgrowth of contaminating cells during cultivation. 
Similarly, the results of the costaining for E-cadherin and vWF positivity in CTB and STB confirmed 
the epithelial character of the isolated and cultivated cells. The predominantly negative staining for 
vWF, ranging from 0.37 to 1%, illustrates the negligible contamination by endothelial cells, 
Figure 1. Morphology of trophoblast cells. (A) Primary undifferentiated cytotrophoblasts (CTB) were
cultured as described in Materials and Methods. After 24 h cultivation cells show characteristics of
mononucleated epithelial cells with well-demarcated cell borders and large nuclei as highlighted by the
red arrows; and (B) after 3 days of cultivation CTB fused to form multinucleated entities representing a
syncytium (STB) as indicated by the red arrows. STB appear as a single continuous layer without cell
borders. Bright field images were captured at 10× magnification. Trophoblasts were isolated from a
healthy human placenta at term.
2.1.2. Protein Expression of Specific Cell Type arkers
The purity of CTB and STB was evaluated by analyzing the cellular expression of cytokeratin
(CK)7, vimentin, von Willebrand factor (vWF), and E-cadherin by flow cytometry. CK7 and E-cadherin
have been chosen, because they are commonly used markers for epithelial cells [28,29]. We also
assessed to which extent potential cellular contamination by mesenchymal cells or endothelial cells
occurred and/or have been propagated with cultivation. To this end, the expression of vimentin and
vWF was analyzed to evaluate the presence of mesenchymal and endothelial cells, respectively [28–30].
As shown in Figure 2B (left and right panels), there were clear increases in fluorescence as compared
to the isotype controls, indicating that both CTB and STB express high levels of CK7. The degree of
CK7 positivity in CTB and STB was above 85% (Figure 2A,B), suggesting high purity and stability of
the trophoblast cultures. Additional purification by negative immuno-magnetic selection [13] was not
performed due to the lack of substantial improvement of purity.
The cellular costaining for CK7 and vi entin positivity confir ed the predo inantly epithelial
character of the isolated cells: CK-positivity ranged fro ~84 to 86%, hile vi entin-positivity as
between ~8 and 12% (Figure 2C,D). These data indicated the absence of significant esenchy al
conta inations and excluded the propagation/overgrowth of contaminating cells during cultivation.
Si ilarly, the results of the costaining for E-cadherin and v F positivity in CTB and STB confir ed
the epithelial character of the isolated and cultivated cells. The predo inantly negative staining for
v F, ranging from 0.37 to 1%, illustrates the negligible contamination by endothelial cells, supporting
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the homogeneity of the cell isolation. In summary, CTB and STB were pure and stable throughout
the experimentally applied culture conditions and time, allowing an unbiased interpretation of the
consecutive in vitro cholesterol transport assays.
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Figure 2. Protein expression of cell-specific markers in CTB and STB cultures. Protein expression of
cytokeratin (CK) 7 and vimentin (vim), specific markers for epithelial cells and mesenchymal cells,
respectively. (A–D): Representative protein expression patterns of CK7 and vim in isolated trophoblasts
after 24 h (undifferentiated trophoblasts; CTB, panel (A) and (C)) and 72 h (differentiated trophoblasts;
STB, panel (B) and (D)) of cultivation was assessed by flow cytometry. Specific staining of CK7 and
vimentin is depicted in red; the isotype control staining is shown in blue. The images are shown as
overlays on isotype control. The black lines on panels A and B indicate the positive (CK-7) and negative
(isotype control) expression patterns. Data were evaluated by using FlowJo data analysis software.
2.1.3. Secretion of Syncytial Factors
In a second step, we analyzed whether CTB and STB exhibit physiological features similar to
in vivo conditions [31–33]. Therefore, we compared the gene expression and secretion of human
chorionic gonadotropin (hCG), human placental lactogen (hPL), and endoglin between CTB and STB.
The abundances of hCG and hPL were determined because it has been demonstrated that the expression
of these genes increases with trophoblast differentiation and syncytium formation [31,33]. Endoglin is
strongly expressed on the apical membrane of STB with a possible role in syncytial invasiveness and
angiogenesis [32,34]. Concerning hCG, we found a markedly higher mRNA gene expression in STB
(p < 0.001 and p < 0.05, respectively) as compared to CTB (Figure 3A).
Consistently, hCG protein secretion was greater in STB than CTB (Figure 3B), mirroring the mRNA
gene expression data. These data indicate that STB exhibit in vivo-like characteristics, suggesting
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that our model is suitable to mimic in vivo processes occurring in the placenta. There was a high
correlation between hCG mRNA and protein release (r = 0.7; p = 0.0082), in agreement with data
reported by others [35]. This suggests that hCG mRNA expression per se is a good indicator of
trophoblast differentiation in an experimental setup where protein data are unavailable.
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Figure 3. Expression of syncytial markers. (A,B) The mRNA abundance and protein secretion of human
chorionic gonadotropin (hCG) in primary undifferentiated (CTB) and differentiated (STB) trophoblast
cells. The gene expression of hCG was assessed by real-time RT-PCR and normalized to the reference
gene as described in Materials and Methods [36]. Primary trophoblasts were isolated from healthy term
placentas as described in Materials and Methods. Dat are shown as mean ± SD of 12 independent
experiments measured at least in duplicate . The rotein secreti n of hCG in CTB and STB was
measured by using a human hCG ELISA kit following the manufacturer’s instr ctions. Data are hown
s mean ± SD of t least three independe t xperiments; and (C,D) The mRNA abundance of human
placental lactog (hPL) and endoglin in CTB and STB was evaluated described abov for hCG. Data are
shown s mean ± SD of three independent exp riments measured at least in duplicates.
Moreover, we found that hPL (Figure 3C) and endoglin (Figure 3D) mRNA levels were higher in
STB (p < 0.005 and p < 0.005, respectively) than in CTB. Considering that endoglin is involved with
trophoblast differentiation in the invasive pathway [32,34], the increased mRNA expression in STB as
compared to CTB confirms the successful in vitro trophoblast differentiation and syncytium formation.
In conclusion, the investigated trophoblast cells represented a highly physiological model and were
suitable for the study of cholesterol transport, including directionality, in and/or across the placenta.
2.2. Cholesterol Transport in CTB and STB
Considering that discrepancy in cholesterol transport capacities may exist between CTB and STB,
we compared their expression profiles for SR-B1, LDL-R, ABCA1, SREBP-2, and apoA-1, as well as their
cholesterol transport activity (inward and outward) to identify potential differences and compensatory
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mechanisms. These comparisons were also performed in cells treated with T0901317, an agonist of
LXR, because this nuclear receptor is a key regulator of many genes implicated in cellular cholesterol
homeostasis [21,37].
2.2.1. Gene Expression Studies
We determined the mRNA expression of ABCA1, responsible for cellular cholesterol efflux [12,13],
and of SR-B1 and LDL-R, which are associated with the bidirectional transport and uptake of cholesterol,
respectively [24,38]. As the placenta is a steroidogenic tissue, we also assessed in CTB and STB candidate
genes representing either cholesterol synthetic capacities (SREBP-2) or autocrine and paracrine pathways
regulating cholesterol transport (e.g., by apoA-1-mediated effects). It is well known that diverse effector
proteins (e.g., hormones) released by a secretory cell can either act directly on itself and regulate cellular
functions (autocrine effect) or can affect the neighboring cells (paracrine effect). We hypothesized that
similar autocrine and paracrine effects by endogenous apoA-1 may occur in the context of cholesterol
transport regulation in trophoblast cells. The primers used for the amplification of target genes are listed in
Table 1.
Table 1. Primer characteristics.
Gene Accession Number Primer Pairs (5’ end to 3’ end) Product Length (bp)
ABCA1 XM_011518342.3 For: CCACATTTTTGCCTGGGACGRev: AGCGATTCTCCCCAAACCTT 88
ApoA-1 NM_001318021.1 For: AGCGGCAGAGACTATGTGRev: CTGTCCCAGTTGTCAAGG 83
Endoglin NM_001114753.2 For: CAAGACCAGGAAGTCCATARev: CGTGTGCGAGTAGATGTA 174
LDL-R XM_011528010.2 For: GACGTGGCGTGAACATCTGRev: CTGGCAGGCAATGCTTTGG 111
SR-BI NM_005505.4 For: CGGCTCGGAGAGCGACTACRev: GGGCTTATTCTCCATGATCACC 76
SREBP-2 XM_017028922.2 For: CCTTCCTCTGCCTCTCCTTTRev: CACAAAGACGCTCAGGACAA 200
YWHAZ XM_024447266.1 For: CCGTTACTTGGCTGAGGTTGRev: AGTTAAGGGCCAGACCCAGT 143
Primers used for the quantitative RT-PCR measurements of apoA-1 and endoglin, were designed using Beacon DesignerTM
software. The remaining primers were taken from previous studies [14,39,40]. ABCA1: ATP-binding cassette transporter
A1, ApoA-1: apolipoprotein A1, LDL-R: Low density lipoprotein receptor, SR-B1: scavenger receptor B 1, SREBP-2: sterol
response element binding protein 2, and YWHAZ: Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation
protein, zeta polypeptide.
Our data showed no statistically significant difference in SR-B1 mRNA expression between CTB
and STB at steady state conditions (i.e., without additional stimulation; p = 0.50), while an increased
expression (p = 0.041) was observed in cells treated with the LXR agonist T0901317 (Table 2).
The differential abundance of SR-B1 mRNA between CTB and STB was observed only after LXR
induction by T0901317, because the SR-B1 gene contains an LXR response element [41] supposedly
potentiating differences between the two cell stages. These results suggested also marked differences
in SR-B1 mediated cholesterol uptake between CTB and STB after exposure to an LXR agonist, which
indeed occurred (Table 2, see also below). Interestingly, the gene expression of LDL-R, another
cholesterol uptake gene, was markedly increased in CTB (p = 0.068) and STB (p = 0.0078) after treatment
with T0901317 (Table 2). There was no differential abundance of LDL-R between CTB and STB neither
before nor after treatment. This suggests a universal role of LDL-R in cholesterol uptake of trophoblast
cells independent of their differentiation stage.
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Table 2. Expression of selected cholesterol homeostasis genes and corresponding cholesterol uptake
rates in CTB and STB.
Steady State LXR Agonist Stimulation
CTB STB CTB STB
mRNA Levels
SR-B1 (×10−3) 13.4 ± 5.90 15.0 ± 5.95 A 16.4 ± 4.90 X 21.2 ± 5.98 B,Y
LDL-R (×10−3) 14.8 ± 8.7 a,* 15.8 ± 10.9 A 67.1 ± 54.6 b,* 44.5 ± 25.9 B
ABCA1 (×10−3) 13.7 ± 8.76 a 21.0 ± 20.4 A 132.8 ± 76.9 b 117.8 ± 42.0 B
SREBP-2 (×10−2) 3.6 ± 2.2 a 4.7 ± 4.4 A 8.6 ± 5.5 b 7.4 ± 3.2 B
ApoA-1 (×10−5) 6.9 ± 3.6 9.7 ± 12 6.6 ± 5 6.3± 2.7
Cholesterol Uptake (CU)
% CU 13.5 ± 3.60 15.1 ± 3.98 A 13.4 ± 3.75 X 21.8 ± 3.49 B,Y
Correlation Coefficients
CU vs. SR-B1 mRNA r = −0.3;p = 0.302
r = 0.5;
p = 0.094
r = 0.2;
p = 0.478
r = 0.2;
p = 0.56
CU vs. LDL-R r = −0.52;p = 0.078
r = −0.16;
p = 0.60
r = 0.59;
p = 0.04
r = −0.07;
p = 0.80
CU vs. SREBP-2 mRNA r = 0.7;p = 0.010
r = 0.6;
p = 0.041
r = 0.8;
p = 0.004
r = 0.2;
p = 0.57
Data are mean ± SD of at least three independent experiments. a,b: different small letters indicate significant
(p < 0.05) treatment effect in CTB. A,B: different capital letters indicate significant (p < 0.05) treatment effect in
STB. X,Y: different letters indicate significant (p < 0.05) differences between CTB and STB within each treatment
regime (i.e., steady state and LXR agonist stimulation, respectively). T0901317 (0.1 µM) was used as LXR agonist.
CTB: primary undifferentiated trophoblast cells, STB: differentiated trophoblast cells, SR-B1: scavenger receptor B 1,
LDL-R: low density lipoprotein receptor, ABCA1: ATP-binding cassette transporter A1, SREBP-2: sterol response
element binding protein 2; apoA-1: apolipoprotein A1. * p ≤ 0.1.
On the other hand, we found that the ABCA1 mRNA level was significantly higher in STB
than CTB (Table 2), suggesting a greater cholesterol efflux capacity in STB. Consistent with data
published elsewhere [20,42], ABCA1 mRNA was significantly induced (by a factor of approximately
10 in the current study) after LXR agonist treatment both in CTB and STB (Table 2). In summary,
the increased SR-B1 and ABCA1 mRNA levels in STB as compared to CTB may predict that
increased cholesterol uptake by cells is accompanied by enhanced cholesterol release through an
ABCA1-dependent mechanism.
To get insights into the associations between cholesterol uptake, endogenous cholesterol synthesis,
and cholesterol release, we also compared the mRNA expression levels of SREBP-2 between CTB
and STB. SREBP-2 is a transcription factor that upregulates the endogenous cholesterol synthesis
and increases cholesterol uptake in response to cholesterol deficiency [22]. Our data did not show
differential SREBP-2 mRNA expression patterns between CTB and STB independent of LXR stimulation.
This predicts that SREBP-2-dependent compensatory mechanisms (for instance in CTB) are not
prominently involved in the differential SR-B1 mRNA expression between CTB and STB (Table 2).
Furthermore, our data showed a significant response to LXR agonist treatment, resulting in an increase
of SREBP-2 expression in both CTB and STB. This is in contrast to previous findings reporting a lack of
LXR promoting effects on SREBP-2 mRNA expression in trophoblast cells [42]. This discrepancy might
be due to the high variability reflected by the high standard deviations of SREBP-2 mRNA expressions
documented in that study.
Concerning the potential autocrine and/or paracrine regulation of cholesterol transport, we found
that apoA-1 mRNA expression levels did not vary between CTB and STB, and were also unaffected
by treatment with the LXR agonist (Table 2). In this context, our own observations also revealed that
STB secrete tendentially more apoA-1 (1.6-fold; n = 3) than CTB confirming the corresponding apoA-1
mRNA data.
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2.2.2. Cholesterol Uptake: Inward Transport
In the next step, we compared cholesterol uptake rates in CTB and STB (Table 2). We assumed that
inward cholesterol transport capacities are critically important for the transport of maternal cholesterol
to the fetus when fetal maturation occurs. In the current study, we observed, at steady-state conditions,
a trend towards greater cholesterol uptake rates in STB as compared to CTB (Table 2). The uptake rates
were significantly enhanced after exposure to the LXR agonist and showed a significant difference
between STB and CTB (Table 2). These data indicate differential inward cholesterol transport rates
of trophoblasts, dependent on their differentiation state. Considering the similar SREBP-2 gene
expression between CTB and STB, the difference in the uptake rates does not seem to be related to
differential intrinsic SREBP-2 dependent cellular mechanisms. In this regard, we found significant
correlations between SREBP-2 mRNA abundance and cholesterol uptake in both CTB and STB at
steady state conditions (Table 2). These findings confirm the importance of the SREBP-2 pathway in
regulating cholesterol transport processes in trophoblasts.
We further observed markedly increased inward cholesterol transport rates in both CTB and STB
after treatment with the LXR agonist (Table 2). This finding is consistent with other studies [16,43], which
reported that LXR enhances maternal cholesterol delivery to the fetus. Thus, our data confirm the role
of SR-B1 as an LXR-dependent mechanism controlling inward cholesterol uptake rates. This mechanism
is still important at term pregnancies, because the maternal cholesterol delivery is required for covering
fetal demands. Impaired fetal maturation and neonatal health were observed in case of disturbed maternal
cholesterol delivery during late gestation [3]. In the current study, we did not find statistically significant
correlations between cholesterol uptake rates and SR-B1 expression in STB exposed to an LXR agonist
(Table 2). However, this correlation was seen in unstimulated STB (Table 2). This apparent discrepancy
could be due to the fact that cholesterol uptake rates are not exclusively driven by SR-B1 [24,38]. In this
context, we also observed that cholesterol uptake was significantly correlated with LDL-R in CTB treated
with LXR-agonist (Table 2).
2.2.3. Cholesterol Efflux: Outward Transport
Next, we evaluated the outward directed cholesterol transport and focused herein on the
apoA-1 mediated efflux, i.e., ABCA1-dependent transport mechanism for the following reasons:
Firstly, a very recent study carried out in primary trophoblasts indicated that increased ABCA1 protein
levels led to an elevation of cholesterol efflux, while a reduction in ABCA1 resulted in suppressed
cholesterol efflux [20]. Secondly, previous studies from us, and others, have reported that, despite
of the localization of both ABCA1 and ABCG1 in placental tissues and cells [11–13], only placental
ABCA1 expression (but not ABCG1) exhibits a gestational-age-dependent expression pattern [14],
suggesting a key role of this protein in transplacental cholesterol transport during gestation.
In the current study, we found a markedly higher level of apoA-1 mediated cholesterol efflux in
STB than in CTB (p = 0.0068) after LXR agonist treatment. On the other hand, in both CTB and STB,
the apoA-1 mediated efflux was significantly promoted by the LXR agonist (Figure 4A), consistent with
data reported by others [20]. The increase of ABCA1-mediated cholesterol efflux (~up to 2-fold) was
less pronounced in comparison with the magnitude of ABCA1 mRNA upregulation (~up to 10-fold).
A similar relationship between ABCA1 mRNA expression and apoA-1 dependent efflux was previously
reported by others in trophoblasts [44] and in human fetoplacental endothelial cells [43].
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In addition, as shown in Figure 4B, the major implication of ABCA1 in apoA-1 mediated efflux
in trophoblast cells was demonstrated. Indeed, there was a drastic suppression of cholesterol efflux
observed in STB in the presence of probucol, an inhibitor of ABCA1 function [45]. A similar
effect of probucol was observed in CTB. These findings confirm the prominent role of the
apoA-1/ABCA1 pathway in mediating cholesterol transport.
2.3. Directionality of the Cholesterol Transport and ABCA1 Localization
The importance of the apoA-1/ABCA1 pathway in mediating the transplacental cholesterol
transport is ll- c t [11,12,14]. However, it still remains unclear whether, or to what
extent, this p thway is involved in dispatching maternal cholesterol to the l i f t s close to
parturition time. Therefore, the directionality of the apoA-1/ABCA1-mediated outward cholesterol
transport was an lyzed, using the Transwell® system with an STB monolayer derived from term human
primary trophoblast cells. This cell model has already been thoroughly validated as useful system to
study transplacental nutrient tra sport [46]. Unexpectedly, we found that apoA-1/ABCA1-mediated
cholesterol efflux occurred predominantly at the apical (maternal) side, whereas only minor transp rt
could be detected at the asal side of STB (Figure 5A).
The herein reported predominantly apically directed cholesterol transport argues against the
hypothesized role of apoA-1/ABCA1 in the delivery of maternal cholesterol to the developing fetus.
In this context, it is important to note that the biophysical and biochemical properties of the STB
monolayers in the current study were similar to those previously reported [46]. Consistent with the
observed cholesterol transport orientation, the Z-stack confocal image analysis showed markedly
higher ABCA1 protein expression at the apical outer membrane (Figure 5C) than at the basal side
(Figure 5D) of the STB.
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Transwell® system. (A,B) The confluent trophoblast monolayer was loaded with 1 µCi of 3H-cholesterol at
the apical side for 24 h. After equilibration, 10 µg/ml of apoA-1 was added to the apical panel (A) or the
basal side panel (B) for 8 h. Data are shown as mean± SD from a representative experiment. Details of the
efflux procedure are described in Materials and Methods, and (C,D) representative immunofluorescence
staining of ABCA1 in the confluent STB monolayer. The orthogonal projections through the Z-stack
suggested that ABCA1 (green) is predominantly expressed at the apical side (Figure 5C) while it was
barely detectable at the basal side (Fig re 5D) of the STB monolayer. Nuclei were counterstained with
4’,6-diamidino-2-phenylindole (DAPI, blue). The horizontal and vertical red arr ws on the orthogonal
plane show the level of the selected stack. The upper level of t stack shown by t red label on the right
corner of the image (Figure 5C) co responds to the apical out r membrane. The bottom l ve stack marked
by the red label on the right corner of the image (Figure 5D) corresponds to the basal outer membrane of
the STB. Details of the staining procedure are described in Materials and Methods.
Taken together, these data imply that, at term, the apoA-1/ABCA1 pathway predominantly
acts in transporting cholesterol back to the maternal circulation. To the best of our knowledge,
this has not been demonstrated so far in a physiological system such as primary term human
trophoblasts. Indeed, the successful establishment of a confluent monolayer with primary trophoblasts
isolated from term placenta has only recently been achieved [46]. Until then, cell-based vectorial
cholesterol transport studies using primary trophoblast cells have been considered as unrealistic [44]
and aternal–fetal cholesterol transport processes were mainly investigated in BeWo cells, a first
trimester derived choriocarcinoma cell line. These cells have been described to express, in comparison
with differentiating trophoblasts, significantly l wer abundances of ABC transporters such as the
multidrug resistance protein (MDR) 1/P-glycoprotein (P-gp), the P-gp homolog MDR3, breast cancer
resistance protein, a d multidrug resistance protei s 1 and 2 [47]. However, the comparative expression
patt rns of ABCG1 and ABCA1 w re not reported in this study [47]. Other investigations demon trated
a greater protein expression level of ABCG1 in BeWo as compared to place ta tissues [48], but again
ABCA1 expression was not shown. A study investigating vectorial cholesterol transport in BeWo cells
failed to demonstrate the efflux of cholesterol to apoA-1 at the basal (fetal) side [49]. However, basally
oriented transport was observed when fetal human serum or phospholipid vesicles were used as
acceptors. Despite the apparent importance of ABCA1-mediated cholesterol efflux, no ABCA1 mRNA
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or protein expression data were reported [49]. Of note, BeWo cells are derived from a first trimester
placenta. Therefore, caution might be required in the direct comparison of the apoA-1-mediated
cholesterol transport data obtained in BeWo cells (indicating lack of cholesterol efflux to apoA-1 at
the fetal side) and the present findings in term placentas (demonstrating predominantly apically, i.e.,
maternally oriented cholesterol transport).
The underlying physiological reasons for the transport orientation seen in the present study have
not been investigated so far. However, it is tempting to speculate that the placenta acts in this way
to protect the fetus from excess cholesterol transfer. Indeed, there are reports suggesting that excess
cholesterol can promote the formation of atherosclerotic plaques in the fetus, thereby programming the
occurrence of metabolic diseases later in life [50,51]. Alternatively, the transport orientation towards
the mother could also serve to avoid cholesterol accumulation in the placenta, thereby reducing the
risk of increased endogenous steroid hormone secretion and concomitant harmful fetal exposure.
In this regard, it is known that antenatal exposure to excess steroid hormones is harmful for the fetus.
It leads to decreased birth weight and increased vulnerability of the fetus to develop serious diseases
later in life [52,53]. Since data reported here are obtained exclusively from term placentas, it cannot be
excluded that the directionality of the apoA-1/ABCA1 mediated cholesterol transport is reversed at
early stages of pregnancy, when the fetus is fully dependent on maternal cholesterol supply. To clarify
this aspect, transport studies with trophoblast cells isolated from first trimester placentas are required.
3. Materials and Methods
3.1. Human Placental Tissue Collection
Placental tissues were collected after obtaining informed consent from pregnant women at the
Division of Gynecology and Obstetrics of the Lindenhofgruppe, Bern, Switzerland. The study was
conducted in accordance with the Declaration of Helsinki, and the protocol was approved by the Ethics
Committee of the Canton of Bern (Basec Nr. 2016-00250; 14/04/2016). Term placentas (38–40 weeks;
n = 17) were collected from uncomplicated pregnancies after elective caesarean section without prior
labor symptoms upon patients’ request or due to breech presentation.
3.2. Isolation of Primary Trophoblasts and Cell Culture
Villous trophoblast cells were isolated from term placental tissue by enzymatic digestion and Percoll
gradient separation, as previously described [13] with minor modifications. In brief, approximately
50 g of villous tissue was washed in 0.9% NaCl (Sigma, Saint Louis, MO, USA) four times for 5 min.
Thereafter the tissue was minced and digested four times with 0.25% trypsin (Sigma, USA) and 300 IU/mL
deoxyribonuclease I (Sigma, Saint Louis, MO, USA) at 37 ◦C (20 min each). The cell suspension was filtered
and overlayed on fetal bovine serum (FBS, Seraglob, Schaffhausen, Switzerland). After centrifugation at
1000× g for 15 min at 10 ◦C, the cell pellet was collected in Dulbecco’s modified Eagle’s medium containing
4.5 g/L glucose (DMEM-HG, Gibco, Paisley, UK) basic medium (without FBS) and filtered through
100 µm strainer (BD Biosciences, Durham, NC, USA). Next, cells were overlayed on a discontinuous
Percoll® (Sigma, Saint Louis, MO, USA) density gradient. After centrifugation, CTBs were located at
the layer corresponding to 1.046–1.065 g/mL (35% to 50%) density [26]. The isolated cells were cultured
at a density of 0.2× 106 cells/cm2 and 0.5× 106 cells/cm2 in 6-well or 24-well CellBIND plates (Costar,
Kennebunk, ME, USA), respectively, using complete DMEM-HG medium (including 10% FBS and 1×
antibiotic-antimitotic (Gibco, Grand Island, NY, USA).
3.3. Cell Morphology
Cultured CTB on 24-well CellBIND plates were inspected by microscopy. After 24, 48, and 72 h of
cultivation bright-field images of CTB and STB were captured using a Leica DMi1 inverted microscope
(Leica, Wetzlar, Germany). The images were processed with the corresponding Leica Software to
compare changes in cell morphology between day 1 and 3.
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3.4. Flow Cytometry Analysis of Cell Purity
The purity of CTB and STB was evaluated by staining the trophoblast cells with specific cell
markers followed by flow cytometry analysis. Cells were grown on CellBIND plates, detached
by accutase (Sigma, Saint Louis, MO, USA), and fixed with 4% formaldehyde (Thermo Scientific,
Rockford, IL, USA) for 10 min on ice. After washing with Dulbecco’s phosphate buffered saline
(DPBS; Sigma, Saint Louis, MO, USA), cells were centrifuged at 200× g for 10 min at 4 ◦C and then
permeabilized with 0.5% Tween-20 (w/v) (Sigma, Saint Louis, MO, USA) in DPBS for 15 min at
room temperature. For evaluation of cell purity, dual staining of CTB and STB with directly labeled
antibody cocktails, prepared in staining buffer (5% FBS, 0.1% Tween-20 (w/v) in DPBS), has been
performed. Antibody cocktails contained either anti-CK7, labeled with Alexa Fluor 488® (Novus
Biologicals, Littleton, CO, USA) plus anti-vimentin labeled with Alexa Fluor 647® (Novus Biologicals,
Littleton, CO, USA) or anti-E-cadherin, labeled with Alexa Fluor 488® (Novus Biologicals, Littleton,
CO, USA) plus anti-vWF labeled with Alexa Fluor 647® (Novus Biologicals, Littleton, CO, USA).
Cells were incubated with the respective antibody cocktail for 45 min on ice, followed by 2 times
washing (1 min each). After centrifugation at 200× g for 10 min at 4 ◦C, pelleted cells were suspended
in DPBS and acquired by flow cytometry (BD FACS LSRII; BD Biosciences, San Jose, CA, USA).
Data acquisition and analysis for each staining was based on at least 10,000 events and performed
by using BD FACSDiva™ (BD Biosciences, San Jose, CA, USA) and FlowJo® software version-10
(FlowJo LLC, Ashland, OR, USA). Since CTB and STB are epithelial cells, positive staining for CK7 and
E-cadherin served as positive cell markers [28,29]. On other hand, vimentin, known to predominantly
stain mesenchymal cells, fibroblast, and stromal cells [28–30], and vWF selectively staining endothelial
cells, served as negative markers for CTB and STB. These staining procedures allowed the assessment
and quantification of potential cellular contaminations by mesenchymal cells, fibroblasts, stromal cells,
and endothelial cells, respectively.
3.5. Quantitative RT-PCR
Quantitative RT-PCR was performed as described previously [54]. Total RNA was extracted
using Trizol reagent (Invitrogen, Grand Island, NY, USA). RNA concentration was quantified
with the NanoDrop 1000 (Thermo Fisher Scientific, Wilmington, DE, USA) by measuring the
absorbance at 260 nm. Additionally, the OD 260/230 and the OD 260/280 ratio showing RNA purity
were determined.
Varying amounts of total RNA were then reverse transcribed to cDNA with the GoScript™ Reverse
Transcriptase System (Promega, Madison, WI, USA) according to the manufacturer’s instructions.
RT-PCR was performed on a ViiA™7 RT-PCR System by using SYBR® Green PCR master mix detection
kit (Promega, Madison, WI, USA). The mRNA expression of selected syncytial markers, namely hCG,
hPL, and endoglin, was compared between day 1 and 3 and served as markers confirming STB formation.
SR-B1, ABCA1, apoA-1, and SREBP-2 represent important components of cellular cholesterol uptake,
transport, and cholesterol homeostasis. Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation
protein, zeta polypeptide (YWHAZ) was selected as endogenous reference gene [14]. All quantitative
PCR experiments were performed with nontemplate negative controls and measured on the ViiA™
7 Real-Time PCR System (Applied Biosystems, Carlsbad, CA, USA). The gene expression of targets
was calculated by using 2−∆Ct method, as previously described [36]. Characteristics of the target genes
and the applied primers are listed in Table 1.
3.6. ELISA for hCG Secretion
The secretion of hCG protein into CTB and STB culture media was measured by using human
hCG (intact) ELISA kit (Sigma, Saint Louis, MO, USA) following the manufacturer’s instructions.
In brief, hCG standards, negative controls, and culture medium samples, were loaded onto hCG
pre-coated wells and incubated for 2.5 h at room temperature. After four times washing, biotinylated
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detection hCG antibody was added and incubated at room temperature for 1h with gentle shaking.
Thereafter, the wells were washed three times, followed by incubation with HRP-streptavidin solution
for 45 min at room temperature with gentle shaking. The wells were subjected to three additional
washing cycles before adding the ELISA colorimetric TMB (3,3’,5,5’-tetramethylbenzidine) reagent.
After 30 min incubation at room temperature in the dark, the reaction was stopped by adding stop
solution provided in the kit. Consecutive absorbance measurements were carried out at 450 nm on a
Vmax microplate reader (Molecular Devices, San Jose, CA, USA). The concentrations of hCG released
by CTB and STB were extrapolated from the slope of the standard curve.
3.7. Cholesterol Transport Studies
The main objective of this study was to evaluate cholesterol uptake (i.e., inward transport) and
efflux (outward transport) rates in CTB and STB. This was investigated by applying two different
experimental models, namely trophoblast cells grown on conventional culture plates and confluent
human primary trophoblast monolayers using pre-coated polycarbonate inserts (Transwell® system).
3.7.1. Cholesterol Transport in Conventional Plates
Freshly isolated CTB were seeded at a density of 0.5 × 106 cells/cm2 in CellBIND 24-well
plates and allowed to attach for 8 h. Then cells were loaded for 24 h with 1µCi/mL 3H-cholesterol
(PerkinElmer, Boston, MA, USA). For cholesterol transport studies in STB, cells were first allowed to
form multinucleated cell patches (approx. 72h) before being loaded with 1 µCi/mL 3H-cholesterol.
After 24 h loading, cells were equilibrated for 4 h in serum-free DMEM HG medium. Cholesterol uptake
rates were calculated by relating the amounts of radioactivity remaining in the medium to the initially
loaded radioactivity. The cholesterol efflux period was initiated by adding 10 µg/mL of apoA-1
(Sigma, Saint Louis, MO, USA), in serum-free DMEM HG medium for 2, 4, 6, and 8h. After collecting
the efflux medium, the plates were frozen at −20 ◦C for 30 min. The details used for lysate collection
and cholesterol efflux measurements were as previously described [55]. ApoA-1 mediated cholesterol
efflux was obtained by subtracting the efflux value in the absence of apoA-1 from that in the presence
of apoA-1 [55]. Where applicable, cells were exposed to 0.1 µM T0901317 (synthetic LXR agonist;
Sigma, Saint Louis, MO, USA) or 10 µM probucol (ABCA1 inhibitor; Sigma, Saint Louis, MO, USA)
throughout the entire experiment.
3.7.2. Cholesterol Transport in Transwell® System
Our final goal was to determine the directionality of the apoA-1 mediated cholesterol efflux
using STB monolayers grown on Transwell® inserts (Falcon, Durham, NC, USA) consisting of apical
(maternal-like) and basal (fetal-like) compartments. For determining 3H-cholesterol uptake and
efflux, 12 well Transwell® inserts with 0.4 µm pore PET membrane were used which were coated
with Matrigel (BD Biosciences, Bedford, MA, USA) at a concentration of 25 µg/cm2 prior to the
experiment. The procedures used for 3H-cholesterol loading, uptake, and efflux determination were
similar to those described for conventional plates with the exception that 1 × 106 cells/cm2 were
seeded. The cholesterol transport studies were performed on day 7, after having validated both
the tightness and barrier integrity of the STB monolayer, as previously described [46]. In brief,
trans-epithelial electrical resistance (TEER) was measured daily using a Millicell ERS-2 Volt-Ohm
Meter (Millipore, Bedford, MA, USA), as previously described [46]. The TEER value was determined on
the Matrigel-coated inserts in the presence or absence of trophoblast cells. In addition, the monolayer
permeability properties were evaluated by measuring daily the passage of the fluorescence dye Lucifer
yellow (LY; Sigma, Saint Louis, MO, USA) across the trophoblast monolayer as previously described in
detail [46].
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3.8. Immunofluorescent Confocal Microscopy
In addition to determining the biophysical and biochemical properties of the trophoblast
monolayer, the localization of ABCA1 was analysed using confocal microscopy, as previously
described [46]. In brief, the confluent trophoblast monolayers grown on Transwell® membranes
were first fixed in methanol at−20 ◦C for 30 min, and then washed in 0.1 M glycine (Merck, Darmstadt,
Germany) for 15 min. After blocking with a cocktail of 2% bovine serum albumin (Sigma, Saint
Louis, MO, USA) and 4% goat serum (Sigma, Saint Louis, MO, USA) for 1 h at room temperature,
they were incubated with anti-ABCA1 antibody (Novus Biologicals, Littleton, CO, USA) overnight
at 4 ◦C. After washing, the mixture of goat anti-rabbit (H + L) Alexa Fluor 488 (Invitrogen, Eugene,
OR, USA) with 4’,6-diamidino-2-phenylindole (DAPI; Sigma, Saint Louis, MO, USA) was added
for 1 h at room temperature in the dark. Membranes were mounted on glass slides using Mowiol
mounting media (Sigma, Saint Louis, MO, USA). The immunofluorescent staining was examined
using a Nikon C1 confocal system (Nikon, Tokyo, Japan) equipped with a 40× S Fluor oil-immersion
objective. Images were acquired and optimized with EZ-C1 software (Nikon, Tokyo, Japan).
3.9. Statistics
Data analysis and statistical evaluation were performed with GraphPad Prism® software
(GraphPad software, La Jolla, CA, USA). All data are expressed as mean ± SD. Differences in the
mRNA expression, and in cholesterol transport activities between CTB and STB as well as the effects of
treatment were analyzed by using unpaired and paired t-tests, respectively. The correlation coefficients
between cholesterol transport and gene expression as well as between mRNA and protein levels of
hCG were evaluated by using the Pearson correlation test. The level of statistical significance was set
at p < 0.05.
4. Conclusions
The current study provides, for the first time, in vitro cholesterol transport data dependent on the
differentiation stage of human primary trophoblast cells. Data reported in this study show significantly
higher cholesterol transport capabilities in differentiated trophoblasts than undifferentiated
trophoblasts and confirm the key role of LXR-sensitive transporter and receptor proteins in
regulating transplacental cholesterol transport. The results in primary trophoblast cells demonstrate a
predominantly apical cholesterol transport direction at term. These findings suggest that, at least at the
end of pregnancy when terminal maturation of the fetus occurs, the ABCA1/apoA-1 pathway is rather
involved in directing (excess) cholesterol back to the maternal circulation than in dispatching it to the
far advanced developed fetus. Thus, the apoA-1/ABCA1 pathway seems to represent a protective and
selective measure to prevent risks for the fetus arising from the potentially harmful antenatal exposure
to excess cholesterol or cholesterol-derived hormones (e.g., steroid hormones).
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